Teva Pharmaceuticals Near 20-Year Lows
https://seekingalpha.com/article/4332825-teva-pharmaceuticals-near-20-year-lows?source=feed_tag_israel
Mar 18, 2020 -
0
Teva Pharmaceutical Industries Ltd. (TEVA) Gains But Lags Market: What You Should Know
http://www.zacks.com/stock/news/837115/teva-pharmaceutical-industries-ltd-teva-gains-but-lags-market-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-837115
Mar 26, 2020 - Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $7.90, moving +0.77% from the previous trading session.
0
Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know
http://www.zacks.com/stock/news/897134/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-897134
Apr 28, 2020 - In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $10.84, marking a +1.12% move from the previous day.
0
Novartis Reports Data on Inclisiran, CHMP Positive on Zolgensma
http://www.zacks.com/stock/news/845181/novartis-reports-data-on-inclisiran-chmp-positive-on-zolgensma?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845181
Mar 30, 2020 - Novartis (NVS) announces pipeline updates on inclisiran and regulatory updates on Cosentyx and Zolgensma.
0
Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know
http://www.zacks.com/stock/news/859627/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-859627
Apr 07, 2020 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.54 in the latest trading session, marking a +0.85% move from the prior day.
0
Is a Beat in Store for Perrigo (PRGO) This Earnings Season?
http://www.zacks.com/stock/news/891904/is-a-beat-in-store-for-perrigo-prgo-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-891904
Apr 27, 2020 - Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be-reported quarter.
0
Pages: 12
<Page 2